Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

TMS1/ASC: the cancer connection.

B B McConnell1, P M Vertino

  • 1Department of Radiation Oncology and Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia 30322, USA.

Apoptosis : an International Journal on Programmed Cell Death
|January 24, 2004
PubMed
Summary

Silencing of TMS1/ASC expression is linked to cancer development. This review explores TMS1/ASC functions in apoptosis, inflammation, and NF-kappa B regulation, and how its loss contributes to carcinogenesis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Galactic Cosmic Radiation Induces Persistent Epigenome Alterations Relevant to Human Lung Cancer.

Scientific reports·2018
Same author

Leptin promotes the proliferative response and invasiveness in human endometrial cancer cells by activating multiple signal-transduction pathways.

Endocrine-related cancer·2006
Same author

Dual role of TMS1/ASC in death receptor signaling.

Oncogene·2006
Same author

Predicting aberrant CpG island methylation.

Proceedings of the National Academy of Sciences of the United States of America·2003
Same author

Identification and characterization of the human MOG1 gene.

Gene·2001
Same author

TMS1, a novel proapoptotic caspase recruitment domain protein, is a target of methylation-induced gene silencing in human breast cancers.

Cancer research·2000

Area of Science:

  • Molecular biology
  • Cancer research
  • Immunology

Background:

  • TMS1/ASC is a bipartite protein with pyrin (PYD) and caspase recruitment (CARD) domains.
  • Proteins with PYD and CARD domains are crucial in apoptosis and immune responses.
  • Mutations in these proteins are associated with autoinflammatory diseases and cancer.

Purpose of the Study:

  • To review the correlation between TMS1/ASC silencing and cancer.
  • To discuss the functions of TMS1/ASC in apoptosis, inflammation, and NF-kappa B regulation.
  • To explore how loss of TMS1/ASC contributes to carcinogenesis.

Main Methods:

  • Literature review of existing studies on TMS1/ASC.
  • Analysis of evidence linking TMS1/ASC silencing to cancer.
  • Discussion of TMS1/ASC's functional roles and their implications in cancer.

Main Results:

  • Growing evidence supports a link between TMS1/ASC expression silencing and cancer.
  • TMS1/ASC plays roles in apoptosis, inflammatory caspase activation, and NF-kappa B regulation.
  • Loss of TMS1/ASC function is implicated in the development of cancer.

Conclusions:

  • Silencing of TMS1/ASC is a significant factor in cancer development.
  • Understanding TMS1/ASC's functions is key to understanding its role in carcinogenesis.
  • Further research into TMS1/ASC could reveal new therapeutic strategies for cancer.

Related Experiment Videos